An Icahn School of Medicine at Mount Sinai study sheds light on the intricate interplay between mammary adipose (fat) tissue and breast health, and offers exciting possibilities for understanding breast development, lactation, cancer, and obesity and related metabolic disorders.
Cullinan advances multiple myeloma drug CLN-619 to a Phase I study – Pharmaceutical Technology
Share this article The company plans for a Phase I dose-escalation and dose-expansion study with CLN-619. Credits: Lightspring/Shutterstock.com Cullinan Oncology is gearing up to advance